ASXL1 frameshift mutations were associated with a worse prognosis in MDS patients with low blasts (MDS‐LB) (p = 0.043), but not in those with increased blasts (MDS‐IB). The gene discussed is ASXL1; the disease is myelodysplastic syndrome.